HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

End-bridging is required for pol mu to efficiently promote repair of noncomplementary ends by nonhomologous end joining.

Abstract
DNA polymerase mu is a member of the mammalian pol X family and reduces deletion during chromosome break repair by nonhomologous end joining (NHEJ). This biological role is linked to pol mu's ability to promote NHEJ of ends with noncomplementary 3' overhangs, but questions remain regarding how it performs this role. We show here that synthesis by pol mu in this context is often rapid and, despite the absence of primer/template base-pairing, instructed by template. However, pol mu is both much less active and more prone to possible template independence in some contexts, including ends with overhangs longer than two nucleotides. Reduced activity on longer overhangs implies pol mu is less able to synthesize across longer gaps, arguing pol mu must bridge both sides of gaps between noncomplementary ends to be effective in NHEJ. Consistent with this argument, a pol mu mutant defective specifically on gapped substrates is also less active during NHEJ of noncomplementary ends both in vitro and in cells. Taken together, pol mu activity during NHEJ of noncomplementary ends can thus be primarily linked to pol mu's ability to work together with core NHEJ factors to bridge DNA ends and perform a template-dependent gap fill-in reaction.
AuthorsBryan J Davis, Jody M Havener, Dale A Ramsden
JournalNucleic acids research (Nucleic Acids Res) Vol. 36 Issue 9 Pg. 3085-94 (May 2008) ISSN: 1362-4962 [Electronic] England
PMID18397950 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Nucleotides
  • DNA
  • DNA polymerase mu
  • DNA-Directed DNA Polymerase
Topics
  • Cell Line
  • DNA (chemistry, metabolism)
  • DNA Repair
  • DNA-Directed DNA Polymerase (chemistry, metabolism)
  • Humans
  • Nucleotides (metabolism)
  • Recombination, Genetic
  • Templates, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: